Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): A$35.67 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$80.61 Million. In 2025 the company made an earning of -A$6.21 Million a decrease over its 2024 earnings that were of A$7.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year	Earnings	Change
2026 (TTM)	A$35.67 M	-675.23%
2025	-A$6.21 Million	-181.6%
2024	A$7.6 M	-55.62%
2023	A$17.12 M	-199.05%
2022	-A$17.3 Million	-40.38%
2021	-A$29.01 Million	-732.31%
2020	A$4.58 M	-130.53%
2019	-A$15.03 Million	189.85%
2018	-A$5.19 Million	-95.29%
2017	-A$0.12 Billion	308.12%
2016	-A$26.98 Million	-32.37%
2015	-A$39.89 Million	10.11%
2014	-A$36.23 Million	-7.59%
2013	-A$39.2 Million
2011	-A$45.39 Million	-19.39%
2010	-A$56.31 Million	20.87%
2009	-A$46.59 Million	32.26%
2008	-A$35.22 Million	-5.46%
2007	-A$37.26 Million
2004	-A$0.25 Million	12.35%
2003	-A$0.22 Million	-11.1%
2002	-A$0.25 Million	-57.03%
2001	-A$0.57 Million	1.03%
2000	-A$0.56 Million	-53.22%
1999	-A$1.19 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Pfizer PFE	A$10.06 B	27,847.72%	🇺🇸 USA
Neurocrine Biosciences NBIX	A$1.19 B	3,211.08%	🇺🇸 USA
Amicus Therapeutics FOLD	A$0.27 M	-99.23%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	A$2.33 B	6,394.29%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions